��������

Sarah Lin is an experienced professional in the pharmaceutical and clinical research industries, currently serving as a Senior Quality Manager and GxP Auditor for George Clinical since October 2024. Previously, Sarah held the position of Quality Assurance Manager at Linical from March 2020 to September 2024. Earlier in their career, Sarah worked at Astellas Pharma from January 2010 to January 2020, occupying various roles including Clinical Project Manager and Clinical Study Manager. Sarah began their career as a Clinical Research Associate at Pfizer Limited Taiwan from October 2008 to November 2009. Sarah holds a Master of Science in Pharmaceutical Sciences from National Taiwan University and a Bachelor of Science in Pharmacy from Taipei Medical University.